GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Novo Nordisk Gets EU Backing for Ozempic Label Expansion
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $305 Price Target
Amgen Analyst Ratings
Novo-Nordisk A/S's Wegovy is entering the world's third largest country by obesity population, with a starting price of 50 dollars per week.
① The price of Novo-Nordisk A/S's weight loss drug Wegovy in India is about a quarter of its price in the U.S. market; ② The patent protection period for semaglutide will expire next year, and Indian generic drug manufacturers are gearing up; ③ Major competitor Eli Lilly and Co introduced a new weight loss drug in India this March, and the market response has been positive.
Novo Nordisk Rolls Out Weight Loss Drug Wegovy in India, Following Eli Lilly's Mounjaro Launch
Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'